5-235256-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_004168.4(SDHA):c.1177G>T(p.Val393Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,922 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004168.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHA | NM_004168.4 | c.1177G>T | p.Val393Leu | missense_variant | Exon 9 of 15 | ENST00000264932.11 | NP_004159.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHA | ENST00000264932.11 | c.1177G>T | p.Val393Leu | missense_variant | Exon 9 of 15 | 1 | NM_004168.4 | ENSP00000264932.6 | ||
ENSG00000286001 | ENST00000651543.1 | n.1065-1172G>T | intron_variant | Intron 8 of 23 | ENSP00000499215.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152140Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251388Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135862
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461782Hom.: 1 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727198
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152140Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74316
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
- -
The p.V393L variant (also known as c.1177G>T), located in coding exon 9 of the SDHA gene, results from a G to T substitution at nucleotide position 1177. The valine at codon 393 is replaced by leucine, an amino acid with highly similar properties. In a study of 1012 unrelated patients from India with suspected neurological disorders, this variant was observed in a patient with myopathy, who also was heterozygous for SDHA p.A69T; however, the phase (whether in cis or trans) was not specified and further clinical information was not provided (Ganapathy A et al. J. Neurol. 2019 Aug;266:1919-1926). This variant has also been reported in one individual with no personal or family history of PGL/PCC or GIST (Rana HQ et al. Cancers (Basel). 2024 Feb;16(5)). Furthermore, this variant has been detected as homozygous in an individual with no reported features of complex II deficiency (Ambry internal data).This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Mitochondrial complex II deficiency, nuclear type 1 Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Dilated cardiomyopathy 1GG Uncertain:1
- -
not provided Uncertain:1
- -
Paragangliomas 5;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at